Biotech Stocks Top Trending Articles – November 9, 2017

biotech stocks august 16 2017

GT Biopharma Inc. (GTBP) Could Be Looking At a Massive Opportunity

“There is a revolution taking place in the practice of medicine, particularly cancer therapy, and most of that innovation is taking place in the biotech companies,” – Chris Sassouni, health care specialist and co-portfolio manager of the mid-cap growth investment team at Eagle Asset Management. Because of statements like this, the street is heavily focusing on this arena and (GTBP) could hold a key to big potential.

Click Here For Full Report

Ex Roche, Calico Executive Takes CSO Role At GSK

Ex- Roche and Calico vet Hal Barron is now the new CSO and chief of research at big pharma GlaxoSmithKline during a re-structuring from its new Chief Executive Officer Emma Walmsley. The new hire was on the fence since the release of a report from the Financial Times this week that stated its previous research chief Patrick Vallance took on a new endeavor with the U.K government as a science adviser. Vallance will now definitely be leaving, taking up the FT-reported role of government science adviser; he leaves March 2018.

Click Here To See Full Article

BIOTECHSTOCKS,.com is owned by MIDAM VENTURES LLC., a Florida Corporation that has been compensated $800,000.00 by a GT Biopharma Inc. for a period beginning August 1, 2017 and ending Nov. 1, 2017 now extended to October 1, 2017 to publicly disseminate information about (GTBP). We own zero shares.


Please enter your name here
Please enter your comment!